Effect of Denosumab on Inflammatory Osteolytic Lesion Activity in Total Hip Arthroplasty
Condition(s):Revision Surgery of Total Hip ArthroplastyLast Updated:August 29, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Revision Surgery of Total Hip ArthroplastyLast Updated:August 29, 2022Completed
Condition(s):Postmenopausal OsteoporosisLast Updated:December 20, 2022Completed
Condition(s):Denosumab AllergyLast Updated:February 21, 2023Recruiting
Condition(s):OsteoporosisLast Updated:November 25, 2016Unknown status
Condition(s):Langerhans Cell HistiocytosisLast Updated:October 4, 2022Completed
Condition(s):Secondary Osteoporosis; Spinal Cord InjuryLast Updated:March 15, 2024Terminated
Condition(s):Rheumatoid ArthritisLast Updated:February 12, 2020Completed
Condition(s):Postmenopausal OsteoporosisLast Updated:April 28, 2023Recruiting
Condition(s):Bone Cyst Aneurysmal; Pathological Fracture; Recurrent Disease; Refractory TumorLast Updated:January 30, 2018Completed
Condition(s):Healthy AdultsLast Updated:July 22, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.